AbCellera Biologics Inc. (ABCL) Earnings
NASDAQ·Healthcare·Biotechnology
$10.90
+4.16%
Mkt Cap $3.49B
EPS — Estimate vs Actual
Mkt Cap
$3.49B
P/E
—
Fwd P/E
—
P/S
44.07
Rev TTM
—
EPS TTM
-$0.48
NASDAQ·Healthcare·Biotechnology
$10.90
+4.16%
Mkt Cap $3.49B
Mkt Cap
$3.49B
P/E
—
Fwd P/E
—
P/S
44.07
Rev TTM
—
EPS TTM
-$0.48